<DOC>
	<DOCNO>NCT01696110</DOCNO>
	<brief_summary>The study would enrol total 2100 AMI patient undergo PCI one three antithrombotic regimen : bivalirudin alone , unfractionated heparin alone , unfractionated heparin plus glycoprotein IIb/IIIa inhibitor . All enrolled patient would followed-up 30 day , 6 month , 1 year . The purpose study evaluate efficacy safety bivalirudin AMI patient DES .</brief_summary>
	<brief_title>BivaliRudin Acute Myocardial Infarction v Glycoprotein IIb/IIIa Heparin : Randomised Controlled Trial .</brief_title>
	<detailed_description>This prospective , randomize , single-blind , active drug control multicenter clinical research study would enrol total 2100 AMI patient undergo percutaneous coronary intervention ( PCI ) one three antithrombotic regimen : bivalirudin alone , unfractionated heparin alone , unfractionated heparin plus glycoprotein IIb/IIIa inhibitor . All enrolled patient would followed-up 30 day , 6 month , 1 year . The purpose study evaluate efficacy safety bivalirudin AMI patient DES .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<mesh_term>Bivalirudin</mesh_term>
	<mesh_term>Hirudins</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Tirofiban</mesh_term>
	<criteria>1 . Age 18 80 year old 2 . Planned emergency PCI acute myocardial infarction ( STEMI NSTEMI ) Symptom onset within 12h STEMI ( within 24 h patient unrelieved chest pain , continuous ST elevation new develop LBBB ) Symptom onset within 72h NSTEMI 3 . Avoid undergoing revascularization nonculprit vessel within 30 day index procedure . 4 . Provide write informed consent . 1 . Unsuitable PCI ; treatment thrombolysis within 72 hour acute STelevation myocardial infarction ; leave main coronary artery disease ; cardiogenic shock . 2 . Any anticoagulant agent use 48 h randomization . 3 . Active bleed bleed constitution , bleed tendency , include recent retina vitreous hemorrhage ( 1 month ) , GI urinary tract hemorrhage ( 3 month ) , cerebral hemorrhage ( 6 month ) cerebral infarction history ( 3 month ) , etc . ; 4 . Other disease may lead vascular lesion secondary bleeding factor ( active gastric ulcer , active ulcerative colitis , intracranial aneurysm , etc . ) , 5 . Deep puncture major surgery ( include eye brain surgery ) within 1 month . 6 . Suspicious aortic dissection , pericarditis subacute bacterial endocarditis . 7 . Untreated uncontrolled hypertension &gt; 180/110 mmHg . 8 . Hemoglobin &lt; 100 g/L platelet count &lt; 100 * 109 / L. 9 . Elevated AST , ALT level high three time normal upper limit . 10. severe renal insufficiency ( eGFR &lt; 30 mL/min / 1.73 m2 ) . 11 . Heparin induce thrombocytopenia . 12 . Known allergy study drug instrument ( UFH , bivalirudin , aspirin clopidogrel , stainless steel , contrast agent , etc . ) , allergic constitution . 13 . Pregnancy lactation . 14 . Researchers think n't fit participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Bivalirudin</keyword>
	<keyword>Acute myocardial infarction</keyword>
	<keyword>percutaneous transluminal coronary angioplasty</keyword>
</DOC>